Machine learning-based virtual screening and its applications to Alzheimer's drug discovery: a review

KA Carpenter, X Huang - Current pharmaceutical design, 2018 - ingentaconnect.com
Background: Virtual Screening (VS) has emerged as an important tool in the drug
development process, as it conducts efficient in silico searches over millions of compounds …

FP-GNN: a versatile deep learning architecture for enhanced molecular property prediction

H Cai, H Zhang, D Zhao, J Wu… - Briefings in …, 2022 - academic.oup.com
Accurate prediction of molecular properties, such as physicochemical and bioactive
properties, as well as ADME/T (absorption, distribution, metabolism, excretion and toxicity) …

Overview of methods and strategies for conducting virtual small molecule screening

X Fradera, K Babaoglu - Current protocols in chemical biology, 2017 - Wiley Online Library
Virtual screening (VS) in the context of drug discovery is the use of computational methods
to discover novel ligands with a desired biological activity from within a larger collection of …

Ligand-and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia

H Zhang, J Huang, R Chen, H Cai, Y Chen, S He… - Bioorganic & Medicinal …, 2022 - Elsevier
Abstract Cyclin-dependent kinase 9 (CDK9) plays a vital role in controlling cell transcription
and has been an attractive target for cancer treatment. Herein, ten predictive models derived …

Ligand-and structural-based discovery of potential small molecules that target the colchicine site of tubulin for cancer treatment

Q Guo, H Zhang, Y Deng, S Zhai, Z Jiang, D Zhu… - European Journal of …, 2020 - Elsevier
Small molecules targeting the colchicine site of tubulin represent an attractive cancer
treatment strategy. In this study, a total of 468 models derived from 1076 diverse inhibitors …

Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches

D Kang, X Pang, W Lian, L Xu, J Wang, H Jia… - RSC …, 2018 - pubs.rsc.org
The high morbidity and mortality of cancer make it one of the leading causes of global death,
thus it is an urgent need to develop effective drugs for cancer therapy. Vascular endothelial …

Machine learning and biological evaluation-based identification of a potential MMP-9 inhibitor, effective against ovarian cancer cells SKOV3

K Sinha, S Parwez, S Mv, A Yadav… - Journal of …, 2024 - Taylor & Francis
MMP-9, also known as gelatinase B, is a zinc-metalloproteinase family protein that plays a
key role in the degradation of the extracellular matrix (ECM). The normal function of MMP-9 …

Discovering New Agents Active against Methicillin-Resistant Staphylococcus aureus with Ligand-Based Approaches

L Wang, X Le, L Li, Y Ju, Z Lin, Q Gu… - Journal of chemical …, 2014 - ACS Publications
To discover new agents active against methicillin-resistant Staphylococcus aureus (MRSA),
in silico models derived from 5451 cell-based anti-MRSA assay data were developed using …

Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays

L Wang, L Chen, M Yu, LH Xu, B Cheng, YS Lin… - Scientific reports, 2016 - nature.com
Mammalian target of rapamycin (mTOR) is an attractive target for new anticancer drug
development. We recently developed in silico models to distinguish mTOR inhibitors and …

Insight into the structural requirement of aryl sulphonamide based gelatinases (MMP-2 and MMP-9) inhibitors–Part I: 2D-QSAR, 3D-QSAR topomer CoMFA and Naïve …

S Das, SA Amin, T Jha - SAR and QSAR in Environmental …, 2021 - Taylor & Francis
Gelatinases [gelatinase A–matrix metalloproteinase-2 (MMP-2), gelatinase B–matrix
metalloproteinase-9 (MMP-9)] play key roles in many disease conditions including cancer …